Lars M. Asmis, MD

Lars Asmis

Title: Hematologist
Company: Center for Perioperative Thrombosis and Hemostasis
Location: Zürich, Switzerland

Lars M. Asmis, Hematologist at the Center for Perioperative Thrombosis and Hemostasis, has been recognized by Marquis Who’s Who Top Scientists for dedication, achievements, and leadership in health care.

Backed by decades of experience, Dr. Asmis currently runs the Center for Perioperative Thrombosis and Hemostasis in Zürich. The private medical facility caters to patients with bleeding disorders and offers a wide array of related services. Dr. Asmis prioritizes patient-care; he loves being able to make a difference. Previously, he has worked as the head of the Coagulation Laboratory in the Division of Hematology at University Hospital Zurich and as a visiting scientist at Johns Hopkins University, and in the Clinic of Internal Medicine in the Division of Hematology at both Geneva University Hospitals and the University Hospital Inselspital Bern.

Dr. Asmis prepared for his endeavors by earning an Eidgenössische Maturität, Typus B Latein, from Feusi Ruedi Schule in Berne, Switzerland, in 1984 and an MD in medicine at the University of Berne in 1990. He then completed postgraduate coursework in biology and experimental medicine at the University Hospital Inselspital Bern, postgraduate coursework in biology and experimental medicine at the University of Zurich, and a degree in habilitation at the University of Zurich. Additionally, he received certification in both hematology and internal medicine from FMH and a fellowship from the Swiss Foundation of Medicine and Biology.

To keep in touch with his peers and professional community, Dr. Asmis joined prominent professional organizations like the International Society Thrombosis and Haemostasis, Inc., the American Society of Hematology, SGAIM, and Schweizerische Gesellschaft Hämatoloie’ Gesellschaft Thrombose-und Hämostaseforschung. He also authored publications like “Comparison of the efficacy of two human fibrinogen concentrates to treat dilutional coagulopathy in vitro” and “Accuracy and consistency of anti-Xa activity measurement for determination of rivaroxaban plasma levels.”

For more:

Researchgate

ZPTH

Lifetime Achievement

Contact Dr. Asmis

 

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

w

Connecting to %s